Keyphrases
Alleviation
33%
Atrial Natriuretic Peptide
33%
Blockage
16%
Blood Pressure
16%
Blood Pressure Increase
16%
Chronic Administration
16%
Differential Effects
100%
Diuretics
16%
Fibrosis
16%
Glomerular Filtration Rate Decline
16%
High Dose
16%
High Salt
16%
High-salt Diet
16%
Hypertension
50%
Na +
16%
Proteinuria
16%
Renal Damage
16%
Renal Disease
100%
Renin-angiotensin System
16%
Renin-angiotensin System Blockers
16%
Sacubitril
100%
Sacubitril-valsartan
66%
Salt-sensitive Hypertension
100%
Sodium Chloride
33%
Systolic Blood Pressure
16%
Tubular Injury
16%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
16%
Urine Flow
16%
Valsartan
100%
Water Consumption
16%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin
33%
Atrial Natriuretic Factor
33%
Disease
16%
Diuretic Agent
16%
Fibrosis
16%
Kidney Disease
100%
Kidney Injury
16%
Neutrophil Gelatinase Associated Lipocalin
16%
Proteinuria
16%
Renin
33%
Sacubitril
100%
Sodium Chloride
100%
Sodium Ion
16%
Valsartan
100%
Valsartan/Sacubitril
66%